#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic myeloid leukaemia Small cell lung cancer limited stage Congenital leptin deficiency Medulloblastoma Leiomyosarcoma Non-Hodgkin's lymphoma Hairy cell leukaemia recurrent Thromboangiitis obliterans Glioblastoma multiforme Solitary fibrous tumour Vulval cancer Retinal dystrophy Infantile apnoea Albright's disease Skin angiosarcoma More trials…

    Learn about Rare Diseases

    Hereditary ataxia – Treatment Amyotrophic lateral sclerosis Synovial sarcoma metastatic – Treatment Small intestine leiomyosarcoma – Basic Information Familial amyotrophic lateral sclerosis – Diagnostics Cerebral arteriovenous malformation haemorrhagic – Trials in Disease Uterine leiomyosarcoma – Diagnostics Sarcoma – Basic Information Marfan’s syndrome – Life with Disease Ewing’s sarcoma recurrent More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Acetylcysteine Lerodalcibep Potassium Narsoplimab Vinflunine Levobupivacaine Abt-494 Sphingomyelin (Egg) Azathioprine Sasanlimab Clotrimazole Pertuzumab Bi 685509 Clobetasol Propionate Lutetium (177Lu) Edotreotide Apitegromab Sotalol Hydrochloride Db-Oto-5 Tofersen Alemtuzumab More therapies…

    Learn about Your Condition

    Carcinoid tumour pulmonary Acromegaly Hepatic neoplasm Foetal growth restriction Glomerulonephritis acute Methylmalonic acidaemia Plasma cell myeloma Breast proliferative changes Transferrin decreased Staphylococcal bacteraemia Dyspepsia Leukoencephalopathy Hyponatraemia MELAS syndrome Respiratory tract infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cardiac failure chronic

  • A study to compare the effects of BI 690517 and spironolactone on kidney function in patients with heart failure, cardiovascular disease, or chronic kidney disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cardiovascular disorder
    • Cardiac failure chronic
    • Chronic kidney disease
    Investigated Drugs:
    • Bi 690517
    • Empagliflozin
    • Spironolactone
    The Netherlands

  • Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ferric Derisomaltose
    Bulgaria Croatia Czechia Denmark Hungary Latvia +6

  • Study on Vitamin D and Oral Iron for Patients with Chronic Heart Failure and Iron Deficiency

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure congestive
    • Cardiac failure chronic
    • Iron deficiency
    Investigated Drugs:
    • Ferric Carboxymaltose
    • Colecalciferol
    Italy

  • Study on Managing Heart Failure and Kidney Disease in Elderly Patients with High Potassium Risk Using Sodium Zirconium Cyclosilicate

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure chronic
    • Chronic kidney disease
    Investigated Drugs:
    • Sodium Zirconium Cyclosilicate
    Spain

  • Study on Dapagliflozin for Patients with Chronic Right Heart Failure

    Recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac failure chronic
    Investigated Drugs:
    • Dapagliflozin
    Germany

  • Study on Meldonium and Physical Activity for Patients with Heart Failure with Preserved Ejection Fraction

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure chronic
    • Heart failure with preserved ejection fraction
    Investigated Drugs:
    • Meldonium
    Latvia
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!